Liu Y - Search Results

1

Acquired BRAF N581S mutation mediated resistance to gefitinib and responded to dabrafenib plus trametinib.

Liu Y, Zeng H, Wang K, Li Y, Tian P, Li W. Liu Y, et al. Lung Cancer. 2020 Aug;146:355-357. doi: 10.1016/j.lungcan.2020.06.004. Epub 2020 Jun 9. Lung Cancer. 2020. PMID: 32553555

2

[Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer].

Liu Y, Tian P. Liu Y, et al. Zhongguo Fei Ai Za Zhi. 2019 Feb 20;22(2):118-124. doi: 10.3779/j.issn.1009-3419.2019.02.07. Zhongguo Fei Ai Za Zhi. 2019. PMID: 30827329 Free PMC article. Review. Chinese.

3

Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes.

Tian P, Liu Y, Zeng H, Tang Y, Lizaso A, Ye J, Shao L, Li Y. Tian P, et al. Among authors: liu y. J Cancer Res Clin Oncol. 2020 Apr;146(4):935-944. doi: 10.1007/s00432-019-03116-6. Epub 2020 Jan 1. J Cancer Res Clin Oncol. 2020. PMID: 31894386

4

Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.

Tian P, He B, Mu W, Liu K, Liu L, Zeng H, Liu Y, Jiang L, Zhou P, Huang Z, Dong D, Li W. Tian P, et al. Among authors: liu k, liu y, liu l. Theranostics. 2021 Jan 1;11(5):2098-2107. doi: 10.7150/thno.48027. eCollection 2021. Theranostics. 2021. PMID: 33500713 Free PMC article.

5

A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report.

Zeng H, Liu Y, Wang W, Tang Y, Tian P, Li W. Zeng H, et al. Among authors: liu y. Ann Palliat Med. 2021 Jul;10(7):8352-8357. doi: 10.21037/apm-20-2081. Epub 2021 Mar 22. Ann Palliat Med. 2021. PMID: 33832282 Free article.

6

Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.

Zeng H, Huang WW, Liu YJ, Huang Q, Zhao SM, Li YL, Tian PW, Li WM. Zeng H, et al. Front Oncol. 2021 Aug 12;11:685047. doi: 10.3389/fonc.2021.685047. eCollection 2021. Front Oncol. 2021. PMID: 34458139 Free PMC article.

7

Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report.

Zeng H, Tang X, Tian X, Liu Y, Tian P. Zeng H, et al. Among authors: liu y. Immunotherapy. 2023 Feb;15(2):77-83. doi: 10.2217/imt-2022-0073. Epub 2023 Jan 25. Immunotherapy. 2023. PMID: 36695105

8

[Metabonomic study of the urine of rat acute gouty arthritis model].

Zhu HY, Xiao J, Liu YJ, Cui Y, Ye LM, Yin HL. Zhu HY, et al. Among authors: liu yj. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;41(4):660-3. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20848791 Chinese.

9

[Monitoring urine metabolic profiles of rat inflammation model with capillary electrophoresis].

Liu YJ, Miao WJ, Yin HL, Ye LM, Chen C, Zhang ZR. Liu YJ, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;42(4):560-3. Sichuan Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21866649 Chinese.

10

Effect of acupuncture on rats with acute gouty arthritis inflammation: a metabonomic method for profiling of both urine and plasma metabolic perturbation.

Wen SL, Liu YJ, Yin HL, Zhang L, Xiao J, Zhu HY, Xue JT, Ye LM. Wen SL, et al. Am J Chin Med. 2011;39(2):287-300. doi: 10.1142/S0192415X11008828. Am J Chin Med. 2011. PMID: 21476206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,745 results

Search Page

Filters